Publication | Open Access
Effect of high<i>versus</i>low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial
70
Citations
19
References
2021
Year
Among hospitalised COVID-19 patients needing oxygen therapy, high dose of dexamethasone reduced clinical worsening within 11 days after randomisation, compared with low dose.
| Year | Citations | |
|---|---|---|
Page 1
Page 1